1332 results
TAVI: nightmare in the cathlab - Cardiac arrest, aortic root rupture & duct occluder
16 Nov 2025 – From PCR London Valves 2025
Explore critical complications encountered during TAVI procedures in this session, which highlights urgent scenarios such as cardiac arrest from calcific leaflet shift, aortic root rupture, and embolisation events. It also covers salvage techniques like TAVR-in-TAVR-in-SAVR in cardiogenic shock and management of acute left main occlusion with...
TAVI: high coronary risk
16 Nov 2025 – From PCR London Valves 2025
This session addresses the complexities and innovative approaches to managing high coronary risk during TAVI procedures. It features advanced techniques such as the double chimney-stent method, valve-in-valve strategies to prevent coronary obstruction, and challenging cases involving TAVI-in-TAVI. These insights provide practical guidance for interventionalists navigating high-risk...
Challenging TAVI
16 Nov 2025 – From PCR London Valves 2025
This session addresses the complexities encountered in transcatheter aortic valve implantation (TAVI) in challenging anatomical settings. It reviews management of bicuspid valves with calcification, horizontal aorta, coronary artery anomalies, and navigation of difficult angles. Case studies illustrate techniques to optimize commissural alignment and strategies to address...
TAVI: unusual complications
16 Nov 2025 – From PCR London Valves 2025
This session examines rare and unusual complications arising from TAVI procedures. Topics include early recognition and management of frozen leaflets, ventricular septal perforation post-valve-in-valve TAVI, acute leaflet dysfunction, aorto-ventricular fistula formation, and percutaneous closure techniques for fistulas involving the right coronary sinus and right ventricle, emphasizing...
Late-breaking evidence in structural and coronary interventions - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...
New approaches in aortic regurgitation
16 Nov 2025 – From PCR London Valves 2025
Explore new diagnostic and therapeutic approaches for managing aortic regurgitation. This session covers imaging modalities, guideline-directed patient selection, current transcatheter treatment techniques, and emerging TAVI technologies designed specifically for non-calcific aortic valve pathology.
Late-Breaking Trials in transcatheter mitral, tricuspid and aortic interventions - Part 1
16 Nov 2025 – From PCR London Valves 2025
This session presents pivotal late-breaking trials in transcatheter mitral and aortic valve interventions. Explore one-year outcomes from the AltaValve early feasibility study featuring atrial fixation TMVR, interim results from the TARGET study assessing Cardiovalve for tricuspid regurgitation, five-year data on transapical TMVR, and outcomes of TAVI...
Redo TAVI with pre and post dilatation - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a live in a box case, regarding a 93-year-old woman with hypertension, chronic bronchitis, and a history of TAVI with a Sapien 3 23 mm (2016) who presented with symptomatic severe aortic stenosis and mildly reduced LV function (50%). An...
The Silk Road of MedTech
16 Nov 2025 – From PCR London Valves 2025
Discover pioneering MedTech innovations along the Silk Road, including novel sheath designs for minimalist TAVR, self-expanding valves for pure aortic regurgitation, automated CT quantification via deep learning, and first-in-man experiences with cutting-edge valvuloplasty and TEER devices.
TAVI: vascular complications
16 Nov 2025 – From PCR London Valves 2025
This session examines vascular complications associated with transfemoral TAVI procedures, featuring challenging cases such as initial procedural obstacles, complex post-TAVI vascular events, and unusual complications. It also explores advanced techniques like intravascular lithotripsy to optimize TAVI outcomes in patients with severe calcific iliofemoral disease.
Innovations in TAVR: clinical insights and future perspectives
16 Nov 2025 – From PCR London Valves 2025
Presenting featured research on TAVI, this session covers outcomes from centers without on-site cardiac surgery, comparative leaflet modification techniques, conscious sedation protocols, left ventricular health in timing TAVR, and long-term valve durability insights including seven-year follow-up data.
TAVI: high coronary risk - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents advanced strategies to mitigate high coronary risk during valve-in-valve TAVR procedures, including the LLAMACORN technique and chimney stenting to prevent coronary obstruction. It discusses management of misaligned prostheses, complex aortic and coronary anatomies, and innovative approaches such as stent crush techniques to ensure...
Meet the masters: complex TAVI
16 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth exploration of complex Transcatheter Aortic Valve Implantation (TAVI) procedures, emphasizing practical aspects crucial for daily clinical practice. Expert TAVI operators share their extensive experience, providing valuable tips and tricks on case selection, procedural strategies, and managing complications to optimize patient outcomes.
Patient-tailored TAVI in bicuspid and tricuspid aortic stenosis
16 Nov 2025 – From PCR London Valves 2025
This session focuses on patient-tailored TAVI strategies for bicuspid and tricuspid aortic stenosis. It reviews recent comparative studies of TAVI devices, discusses the development of individualized TAVI programs for tricuspid aortic stenosis patients, and provides guidance on selecting optimal devices for those with bicuspid aortic valve...
PARTNER 3: transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years
14 Nov 2025
At 7 years, low-risk patients affected by severe symptomatic aortic valve stenosis 1:1 randomly treated by SAPIEN 3 TAVI or surgery showed similar clinical outcomes and late valve durability
Reviewer
Reviewer
Treating severe restenosis of a 20-mm balloon-expanding valve after a transapical approach with a risk of coronary obstruction
05 Nov 2025
In this challenging redo TAVI case, an 87-year-old woman presented with severe bioprosthetic valve restenosis and advanced heart failure symptoms, eight years after a previous transapical implantation.
Her frailty, prior surgical approach, and complex anatomy—with low coronary heights and a stent frame extending beyond the sinotubular junction—posed...
Author
Author
Author
Author
Author
Author
Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes
27 Oct 2025
Mirvat Alasnag interviews Michael J. Mack on the PARTNER 3 Low-Risk randomised trial he presented at TCT 2025 in San Francisco.
Author
Author
Unusual and high-stakes interventions
11 Oct 2025 – From AICT-AsiaPCR 2025
This session presents a series of unusual and high-stakes interventional cardiology cases that challenge conventional approaches. It includes critical scenarios such as narrow escapes from fatal outcomes, innovative solutions like complete percutaneous repair of adult tetralogy of Fallot, and management of valve complications, providing valuable insights...
Calcium modification and atherectomy
11 Oct 2025 – From AICT-AsiaPCR 2025
This session addresses the challenges of calcium modification and atherectomy in complex coronary interventions. It features case studies on stent deformation, advanced calcium modification strategies including orbital and laser atherectomy, imaging-guided approaches, and management of complications such as stent dislodgement, offering comprehensive insights into contemporary techniques...
Valve and structural: challenges and innovations
11 Oct 2025 – From AICT-AsiaPCR 2025
This session explores innovative approaches and challenges in valve and structural interventions, including expanding transcatheter techniques for ruptured sinus of Valsalva closure and prophylactic chimney stenting in high-risk TAVI patients. It also presents long-term outcomes of left main PCI according to stenting methods, comparative strategies in...
